Australia will soon be joining the medical cannabis revolution. Its federal government has moved to legalize marijuana for medical and scientific purposes, and a Roy Morgan Research poll shows that 91 percent of Australians agree that medical marijuana should be legalized.
The poll, which was released on Monday, asked 644 Australians 14 years of age or older whether the use of marijuana for medical purposes should be made legal or not, with only 7 percent not voting in favor.
Roy Morgan Research CEO Michele Levine told The Guardian that she was not surprised to find the strongest support from those aged 50 and older, as “[t]his group is most susceptible to several of the conditions that medicinal marijuana can provide relief from: Parkinson’s disease, cancer, glaucoma and more.”
The poll results were released less than two weeks after Australia’s federal government announced plans to amend the Narcotic Drug Act 1967 to allow cannabis to be grown for medical and scientific purposes, without breaching international drug treaties.
“This Government is incredibly sympathetic to the suffering of those Australians with debilitating illnesses and we want to enable access to the most effective medical treatments available,” Health Minister Sussan Ley said in a statement.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Under current Australian laws, marijuana is classified as an illegal drug, and while penalties vary from state to state, the growth, use, possession or sale of it is punishable by a fine or jail time.
Even so, some Australian states are already taking steps toward medical marijuana research and development. For example, the New South Wales government just announced that it is committed to spending $9 million to support medical cannabis clinical trials for terminally ill adult cancer patients, making it the first Australian state to do so.
The government of Victoria is taking a slightly different route. It’s looking to legalize access to locally manufactured medical cannabis products for patients with exceptional circumstances and severe symptoms from 2017 onward.
While the individual states don’t have the authority to set rules for the cultivation of cannabis and production of medical marijuana products, the move by the federal government will make it easier.

Medical marijuana stocks

As it stands, there are only three medical marijuana companies listed on the ASX, and two of them are transformed mining companies. The three companies are as follows: MMJ Phytotech (ASX:MMJ), Erin Resources (ASX:ERI) and the most recent addition to the roster, Capital Mining (ASX:CMY).
MMJ Phytotech completed a $15.5-million merger with Canadian MMJ Bioscience in June to become the first ASX-listed medical marijuana company. The company has been working to accelerate its entry into the Australian medical cannabis market, completing a $2-million share placement and beginning a Phase 1 clinical trial of tetrahyrocannabidiol (THC) and cannabidiol (CDB) oral capsules for the treatment of pain and spasticity in multiple sclerosis patients following the federal government’s announcement.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Then there is Erin Resources, a gold explorer that completed a reverse takeover of Israel-based MGC Pharmaceuticals in August; MGC is a medical and cosmetic cannabis company that received two licenses in June to grow, process and trade its cannabis products in Europe.
Capital Mining, the third company, is currently in the process of entering the Australian medical marijuana market through the acquisition of a group of US and Canadian companies, including Denver-based Nutrawerx, Canadian Broken Coast Cannabis and Cannan Growersone.
Those interested in the medical cannabis space will no doubt be watching to see how legalization in Australia moves ahead and what other companies move into the ever-growing market moving forward.
Securities Disclosure: I, Kristen Moran, hold no direct investment interest in any company mentioned in this article.
Related reading: 
Legal Cannabis Stocks in North America
How to Invest in Medical Cannabis
Legalizing Medical Cannabis: A Look at the Laws Surrounding Medical Marijuana

Better Plant Sciences Inc. (CSE:PLNT)(OTCQB:VEGGF)(FSE:YG3) (“Better Plant” or the “Company”), a wellness company that develops and sells sustainable, plant-based products that are better for health and better for the earth, is pleased to announce that it has added The Organic Grocer to its list of retail wholesalers for Jusu Wellness and Jusu Bar products. The Organic Grocer is one of Metro Vancouver’s leading independent organic grocers, providing full service industry leading expertise in health and wellness for its community with a focus on environmental and ecological consciousness

Keep reading... Show less

Gage Growth (CSE:GAGE) CEO Fabian Monaco talks about the company’s latest merger and acquisition partnership with TerrAscend (CSE:TER,OTCQX:TRSSF) and how its different streams of revenue are driving Gage’s exponential growth within the cannabis landscape. 

“In 2021, we really hit the ground running, just like we’re going to hit 2022 running even faster. We had phenomenal growth, quarter-over-quarter growth, and we’re looking to expand quite exponentially as we approach the year 2022 in Michigan,” Monaco said.

Gage entered into a US$545 million definitive arrangement agreement with TerrAscend wherein shareholders of Gage will receive 0.3001 of a common share of TerrAscend for each Gage Share.

This CEO Interview is brought to you by:

Gage Growth (CSE GAGE) is a premier cannabis cultivator, retailer and brand in Michigan that operates on the idea that “good is just not good enough.” Its core values of providing premium cannabis to market, positively shaping cannabis culture and nurturing the community primes the company for success and rapid economic growth.Send me an Investor Kit

The combined business will have operations in five states and in Canada, including seven cultivation and processing facilities and 23 operating dispensaries serving both medical and adult-use cannabis markets in the US and Canada.

Part of the company’s plan for expansion is to bring the phenomenal Cookies brand to Canada. It will be available exclusively in Ontario via the Ontario Cannabis Store, the largest purchaser of cannabis in the world.

“We’re going to bring the Cookies brand to Canada very, very soon. We plan on opening a retail store in Canada and be the first ever Cookies-branded retail store,” said Monaco. 

Watch the full interview with Gage Growth CEO Fabian Monaco above. 

Keep reading... Show less

Specialist Investment Company, MMJ Group Holdings Limited (ASX: MMJ) (“MMJ”), wishes to advise that BevCanna Enterprises Inc.(CSE:BEV) (“BEV” or “BevCanna”) has announced an offer (the Offer) to acquire 100% of Embark Health Inc. (“Embark”). MMJ’s investment in Embark consists of shares and warrants with a current book value of CAD2.4m.

Subject to a review of the Offer documentation, MMJ expects that its share of the Initial Consideration (refer below) would approximate the current book value of MMJ’s investment1.

Keep reading... Show less

Spyder Cannabis Inc. (TSXV:SPDR) (“Spyder” or the “Company“), an established Canadian cannabis and vape retailer, is pleased to announce that its specialty vape retail brand, 180 Smoke, has entered into a strategic supplier agreement with Yi Hao Ji (Canada) Ltd. (“Yi Hao Ji“) to offer RELX closed-pod vaping products across its corporate and franchise stores, e-commerce and wholesale channels.

The closed-pod system is one of the fastest-growing sectors in the vaping vertical. More specifically, in Canada closed vaping systems have a compounded annual growth rate of 25% between 2019 and 2024 and currently account for 44% of all vape-related sales in Canada as compared to 4% prior to 2019[1].

Keep reading... Show less

New High-Tech Hardware System to Launch in 16 States by Year End

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced the release of Cliq by Select, a breakthrough hardware system from its Select brand designed to significantly upgrade the consumer’s vaping experience. Cliq is the culmination of years of research and development to create the perfect marriage of Select’s award-winning cannabis oil with a new, intelligently designed delivery system. This new hardware will debut at Hall of Flowers today and launch in Oregon California and Arizona next week. The hardware will then continue to roll-out nationwide in states such as Massachusetts Colorado Florida Maryland Michigan Nevada New York Connecticut Maine Utah Ohio and Pennsylvania .

Keep reading... Show less